Pharmaceutical science to improve the human condition : Prix Galien 2011 : winners and finalist candidate of the Prix Galien USA Awards 2011.
Malden, Mass. : Wiley Periodicals,
c2012.
"This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases.."--Publisher's description.
Caption title.
"This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases.."--Publisher's description.
Includes bibliographical references.
Development of the IL-12/23 antagonist ustekinumab in psoriasis : past, present, and future perspectives : an update / Newman Yeilding ... [et al.] -- Development and clinical evaluation of Prevnar 13, a 13-valent pneumococcal CRM₁₉₇ conjugate vaccine / William C. Gruber, Daniel A. Scott, and Emilio A. Emini -- The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction / Carsten Goessl ... [et al.] -- Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies / Ira V. Gupta and Roxanne C. Jewell.
Pharmacology.
Pharmaceutical industry.